Product
Cipla-1G-Otic Suspension
Product Information
Product Code:
Cipla-1G-Otic Suspension USP
Product Name:
Ciprofloxacin Hydrochloride Suspension
Active Ingredient:
Ciprofloxacin HCl
Manufacturer:
Cipla
Dosage:
0.25, 1, 3, 6, 12.5, 25, 50, 100, 150, 200
Package Size:
10 ml
Product Form:
Cipla 1G-Otic Suspension USP
Package Type:
Product Description
Cipla-1G-Otic Suspension is an antibiotic that belongs to the group of drugs known asantibiotics.
This medicine is prescribed for the treatment of bacterial infections in the gastrointestinal tract, including anorexia, diarrhea, and infections of the skin, vagina, and gastrointestinal tract.
Ciprofloxacin hydrochloride has bactericidal activity against most bacteria. However, it is not a bactericidal drug.
How to Use:
The recommended dose of Ciprofloxacin Hydrochloride is 1 ml for adults and 1 ml for children 12 years and older. Take Ciprofloxacin Hydrochloride with or without food.
Do not take more than the recommended dose or dose of Ciprofloxacin Hydrochloride to treat bacterial infections.
Ciprofloxacin Hydrochloride Dosage:
Your doctor will determine the appropriate dosage of Ciprofloxacin Hydrochloride for your particular infection. The dosage of Ciprofloxacin Hydrochloride will depend on the type, severity, and type - dosage instructions you provide your doctor.
Ciprofloxacin Hydrochloride Side Effects:
Common side effects of Ciprofloxacin Hydrochloride may include:
If you are on any medications, please inform your doctor or pharmacist if any of the side effects are troublesome or severe enough to be referred to a doctor.
Tell your doctor about all the medicines you take, including prescriptions and over-the-counter medicines, as well as any vitamins and supplements you buy without a prescription from your pharmacy.
Ciprofloxacin Hydrochloride side effects can include:
Tell your doctor if you are pregnant or plan to become pregnant, are breastfeeding, are allergic to any medicines, or if you smoke.
Ciprofloxacin Hydrochloride is contraindicated in children under 12 years, and children under 12 years of age. Ciprofloxacin is not recommended for use in children under 24 months of age.
Ciprofloxacin Hydrochloride is prescribed as the medicine to be used for:
Bacterial infections (e.g., tonsillitis, bronchitis, sinusitis, ear infections, pneumonia, urinary tract infections, genital tract infections, infections of the skin and mucous membranes).
Bacterial infections (e.g.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use in Children 4 years and aboveDrug class not approved by the US Food and Drug Administration.
Drug class not approved by the US FDA.
Drug class not approved by the US Health Advisory Panel.
MedsGo class not approved by the US FDA.
Cipro has been found to contain Ciprofloxacin. The chemical composition of this drug is:
Ciprofloxacin (Cipro) is an antibiotic belonging to the fluoroquinolone family, which is an antifibrotic agent used in the treatment of various bacterial infections. Ciprofloxacin is a broad-spectrum fluoroquinolone, which acts as an effective killing agent. It is used for the treatment of a variety of infections, including infections of the urinary, respiratory, skin, soft tissue, lung and blood. It also used for the treatment of anthrax, Rocky Mountain spotted fever, and other bacterial infections. Ciprofloxacin has also been found to be helpful in preventing and treating urinary tract infections. Ciprofloxacin was first developed by Bayer in 1987.
Ciprofloxacin is an antibiotic belonging to the fluoroquinolone family, which is an antibacterial drug used in the treatment of bacterial infections. Ciprofloxacin is used for the treatment of a variety of bacterial infections, including infections of the urinary, respiratory, skin, respiratory, lung, and blood. Ciprofloxacin has also been found to be helpful in preventing and treating infections of the skin, soft tissue, and lung. Ciprofloxacin was also used to treat urinary tract infections.
The active ingredients are ciprofloxacin, which is a fluoroquinolone, which is used in the treatment of bacterial infections, such as pneumonia. The drug is an antibiotic and it is used to treat a variety of bacterial infections, including pneumonia, urinary tract infections, and infections of the skin, soft tissue, and lung. Ciprofloxacin is used in the treatment of anthrax, Rocky Mountain spotted fever, and other bacterial infections. Ciprofloxacin has also been used to treat anthrax, Rocky Mountain spotted fever, and other bacterial infections.
Ciprofloxacin is an effective drug that is used to treat a wide variety of bacterial infections. The drug belongs to the fluoroquinolone class of antibiotics, which are bacteriostatic drugs used in the treatment of bacterial infections, such as pneumonia, urinary tract infections, and infections of the skin, soft tissue, and lungs. Ciprofloxacin works by inhibiting DNA gyrase and topoisomerase IV, two enzymes that are responsible for breaking down DNA, DNA gyrase and topoisomerase IV. It has also been found to be helpful in the treatment of certain types of infections, such as sexually transmitted infections, respiratory infections, and sexually transmitted diseases. It is also used to treat anthrax, Rocky Mountain spotted fever, and other bacterial infections.
Ciprofloxacin is a quinolone antibiotic that is used for the treatment of bacterial infections. It is an antibiotic that is used to treat a variety of infections, including infections of the urinary, respiratory, skin, respiratory, lung, and blood. It also is used in the treatment of anthrax, Rocky Mountain spotted fever, and other bacterial infections. Ciprofloxacin has also been used to prevent anthrax infection.
The composition of this drug is:
Ciprofloxacin contains two isomers: Ciprofloxacin-I and Ciprofloxacin-III, which are the same antibiotic. The isomers are classified as fluoroquinolones, which are used in the treatment of bacterial infections, such as pneumonia, urinary tract infections, and infections of the skin, respiratory, lung, and blood. They are used in the treatment of bacterial infections, such as pneumonia, urinary tract infections, and infections of the skin, respiratory, lung, and blood. The isomers are further classified as tetracyclines, which are used in the treatment of bacterial infections. Ciprofloxacin has also been found to be helpful in preventing and treating anthrax, Rocky Mountain spotted fever, and other bacterial infections.
The drug is a powerful antibiotic that can kill bacteria, so it is important to use it correctly and to not give it to children and pets. Ciprofloxacin has a good safety profile, so it is recommended that all pet owners use this drug with caution.
Ciprofloxacin is a broad-spectrum antibiotic that is used in the treatment of bacterial infections, such as pneumonia, urinary tract infections, and infections of the skin, respiratory, and blood.
The effect of ciprofloxacin on the in vivo disposition of an antimicrobial agent, ciprofloxacin, was investigated in rats. Ciprofloxacin (1 mg/kg) was given in the absence of other antibiotic, ciprofloxacin (30 mg/kg) and by application of 0.5 mg/kg of ciprofloxacin (30 mg/kg) to rats, the results of a single dose of ciprofloxacin (1 mg/kg) indicated that ciprofloxacin (30 mg/kg) decreased the concentration of the antibiotic. Ciprofloxacin (30 mg/kg) was found to decrease the concentration of ciprofloxacin by approximately 1.5 times after an intravenous injection. The mechanism by which ciprofloxacin reduces the clearance of drug in humans is not yet known. The authors concluded that this agent should be used with caution in patients with renal impairment.
The ciprofloxacin drug, a fluoroquinolone antibiotic, was shown to inhibit the growth ofMycobacterium aviumcomplex (MAC) andMycobacterium tuberculosiscomplex (TB) in the rat. The mechanism by which ciprofloxacin reduces the accumulation of the drug in humans is not known. In order to investigate the mechanism by which ciprofloxacin inhibits the growth ofcomplex, ciprofloxacin was added to the culture medium of rats. The effects of the antibiotic on the drug accumulation were examined using a dose-response model.
Ciprofloxacin, a fluoroquinolone, is an antibiotic belonging to the quinolone class. It has been used extensively as an antibacterial agent for the treatment of infections of the central nervous system, skin, urinary tract and respiratory tract, as well as for the treatment of infections of various body tissues, such as the ear, respiratory tract, urinary tract, gastrointestinal tract, lungs, sinuses, bones, joints, skin, teeth, joints, bones, liver, kidneys, biliary tract, and blood. The antibacterial effect of ciprofloxacin has been shown in vitro to be due to inhibition of the protein synthesis of Gram-negative bacteria, and its mechanism is not completely understood. Ciprofloxacin was shown to have an inhibitory effect on the growth ofM. aviumcomplex in atuberculosisinfection model. In vitro, ciprofloxacin (30 mg/kg) inhibited the growth ofcomplex in vitro by inhibiting the protein synthesis of the bacteria. The inhibition of the growth ofcomplex was attributed to the inhibition of the protein synthesis of macrophages and neutrophils. Ciprofloxacin (30 mg/kg) also inhibited the growth ofcomplex in the mouse skin model. The authors concluded that the inhibition of the protein synthesis ofcomplex by ciprofloxacin is probably due to the inhibition of the protein synthesis ofcomplex.
Ciprofloxacin is a fluoroquinolone antibiotic. It has been used extensively as an antibacterial agent for the treatment of various infections in humans and as a drug of choice in clinical medicine. The bactericidal action of ciprofloxacin is based on inhibition of the protein synthesis ofcomplex, which inhibits the growth ofcomplex by inhibiting the protein synthesis of the bacteria. Ciprofloxacin has been shown to have bactericidal activity against both Gram-negative and Gram-positive bacteria. In addition to its bactericidal activity, ciprofloxacin has been shown to have a broad spectrum of activity against a wide range of Gram-positive bacteria. The bactericidal activity of ciprofloxacin is independent of the dose, duration of treatment, route of administration, and the underlying conditions of the infection. In a study of the effect of ciprofloxacin on the activity ofcomplex, the authors concluded that the bactericidal effect of ciprofloxacin was dose-dependent, with a mean apparent killing of
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$28.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Keep out of the reach of childrenTake for a restCipro 200mg 30 tablets x 2 Packs 10$0.41Product variants Cipro (Ciprofloxacin) 30 tablets x 2 Packs 10$0.41
Healthylife has released a new packaging thatarity concerning the safety of Cipro Tizanidine (500mg) 30 tablets x 2 Packs 10$0.41.
Cipro Tizanidine (500mg) 30 tablets x 2 Packs 10$0.41
Cipro Tizanidine (500mg) 30 tablets x 2 Packs 10$0.
Stade de France Pharmacy